www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

investor base and create favorable capital market environment for the growing elderly population.In pursuing the strategic goals, the SEC is placing a greater importance on proactive communication

@halcyon.co.th No. CS-2563/003 27 February 2020 Subject: Management Discussion and Analysis for the Year Ended December 31, 2019 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public

บริษัท วนชัย กรุ๊ป จำกัด(มหาชน) -Translation- 25 June 2019 Subject : Disclosure of connected transaction Attention : President The Stock Exchange of Thailand Vanachai Group Public Company "VNG" would

บริษัท วนชัย กรุ๊ป จำกัด(มหาชน) -Translation- 25 June 2019 Subject : Disclosure of connected transaction by a subsidiary company Attention : President The Stock Exchange of Thailand Vanachai Group

14 August 2019 Subject: Management Discussion and Analysis for the 6-Month Period Ended June 30, 2019 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public Company

บริษัท วนชัย กรุ๊ป จำกัด(มหาชน) - Translation - 25 May 2018 Subject : Disclosure of connected transaction by a subsidiary Attention : President The Stock Exchange of Thailand Vanachai Group Public

บริษัท วนชัย กรุ๊ป จำกัด(มหาชน) -Translation- 25 June 2018 Subject : Disclosure of connected transaction Attention : President The Stock Exchange of Thailand Vanachai Group Public Company "VNG" would

บริษัท วนชัย กรุ๊ป จำกัด(มหาชน) -Translation- 25 June 2018 Subject : Disclosure of connected transaction by a subsidiary company Attention : President The Stock Exchange of Thailand Vanachai Group

: Management explanation and analysis Quarter 3/2020 ending 30 September 2020 Attention: The President of, The Stock Exchange of Thailand Ziga Innovation Public Company Limited (“the Company”) manufactures and